Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have given a buy […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have given a buy […]
